[Funding Alert] Singapore-Based Gero Raises $2.2 Mn In Series A Round The round was led by Bulba Ventures, along with existing investors and serial entrepreneurs in the fields of pharmaceuticals, IT and AI

By Debarghya Sil

You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.

Pixabay
Representational

Gero, a Singapore-based artificial intelligence (AI) platform that focuses on developing drugs to prevent ageing and other disorders, on Tuesday announced it has received funding worth $2.2 million in a Series A round led by Bulba Ventures, along with existing investors and serial entrepreneurs in the fields of pharmaceuticals, IT and AI.

With this funding, the company has raised a total capital worth $7.5 million.

The latest development has led Yury Melnichek, co-founder of Bulba Ventures, to join Gero's board of directors.

The company said it will utilize the fresh funds to develop its AI platform for analysing clinical and genetic data to find treatments for "complicated" disease" which are age-related chronic illnesses, mental illnesses and others.

Commenting on the funding, Peter Fedichev, founder of Gero, said, "We are happy with the recognition and support from these strategic investors who themselves are acknowledged leaders in the fields of AI and biotechnology. This will help us attain the necessary knowledge at the junction of biological sciences and AI/ML technologies that is necessary for the radial acceleration of drug discovery."

"We hope that the technology will soon lead to a meaningful healthspan extension and quality of life improvement," he added.

The company after analyzing large datasets of medical and genetic information from scores people have found a protein in the blood which if removed or blocked should lead to rejuvenation.

The company said experiments at the National University of Singapore involving aged animals demonstrated mortality delay (life-extension) and functional improvements after a single experimental treatment.

In the future, this new drug could enable patients to recover after a stroke and could help cancer patients in their fight against accelerated ageing resulting from chemotherapy.

The biotech firm's platform is also currently being used to find therapies for COVID-19 treatment.

Debarghya Sil

Entrepreneur Staff

Former Correspondent

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Starting a Business

A Cambodian Refugee Paralyzed By Polio Says 'Not Much' Was Expected of Him. He and His Wife Built a Multimillion-Dollar Business That Beat All Odds.

Steve and Brittany Yeng were discouraged from pursuing their unique idea, but they didn't listen to the naysayers.

Side Hustle

She Quit Her Job at Trader Joe's After Starting a Side Hustle With $800 — Then She and Her Brother Grew the Business to $20 Million

Jaime Holm and Matt Hannula teamed up to build a business in an industry that "didn't exist" yet.

Business News

Barbara Corcoran Finds a Buyer in One Day for Her $12 Million 'Palace in the Sky' Penthouse

Corcoran bought the duplex co-op for $10 million in 2015 and spent $2 million renovating it.